Abstract:Objective To investigate the expression of placental growth factor (PlGF) protein and mRNA in lungs of neonatal rats exposed to 85%hyperoxia, and to establish the relationship between PlGF and bronchopulmonary dysplasia (BPD). Methods Forty-eight Sprague–Dawley neonatal rats were randomly exposed to air (control group)(n=24) and 85% hyperoxia (hyperoxia group)(n=24)within 12 h after birth. The rats were sacrificed at 3, 5 and 7 days after exposure (eight at each time) and their lungs were sampled. PlGF protein and mRNA expression in the lungs were determined by Western blot and real-time polymerase chain reaction (PCR) at 3, 5 and 7 days. Left lung tissue was used for morphological and histological observation with hematoxylin and eosin staining. Terminal air spaces and the secondary septa were counted manually under microscope. T-test was applied for statistics. Results Compared with the control group, morphological and histological analysis in the hyperoxia group revealed inflammatory cell infiltration, simplified alveolar structure, less alveolar, alveolar cavity expansion and thickened alveolar septum. Morphometric measurements showed that terminal air spaces and secondary septa were significantly fewer in the hyperoxia rats than those in the control group at 5 and 7 days (terminal air spaces:23.6±8.2 vs 33.1±6.2 and 28.5±9.2 vs 38.4±10.1, t=1.91, 2.53, all P<0.05;secondary septa:56.0±12.2 vs 78.3±8.2 and 75.4±12.2 vs 126.1±10.2, t=2.14, 2.72, all P<0.05). Real-time PCR showed that expression of PlGF mRNA increased significantly on day 3, 5 and 7 in the hyperoxia group compared with the control group (1.16±0.17, 1.34±0.15 and 1.65±0.19 vs 0.65±0.21, 0.47±0.11 and 0.46±0.17, respectively, t=1.93, 2.55, 2.79, all P<0.05). Western blot also showed that expression of PlGF protein on day 3, 5 and 7 in the hyperoxia group increased compared with the control group, but only being significant on day 3 (0.24±0.17 vs 0.09±0.01, t=2.44, P<0.05). Conclusions Hyperoxia (85%) exposure could increase PlGF protein and mRNA expression in the lungs of neonatal rats, likely contributing to pathogenesis of BPD, and might lead to pulmonary vascular developmental disorders in BPD.

The role of miR-15b and vascular endothelial growth factor in the pathogenesis of novel bronchopulmonary dysplasia in neonatal rats

MicroRNA-mRNA interactions in a murine model of hyperoxia-induced bronchopulmonary dysplasia

Effect of miR-34a-5p on vascular endothelial growth factor in “new BPD” rat model

Effect of the Notch4/Dll4 Signaling Pathway in Early Gestational Intrauterine Infection on Lung Development

[Effect of VEGF Gene Transfer on the Bleomycin-Induced Pulmonary Hypertension in Immature Rabbits].

VEGFmRNA and Enosmrna Expression in Immature Rabbits with Bleomycin-Induced Pulmonary Hypertension.

Involvement of miR-495 overexpression in the pathogenesis of bronchopulmonary dysplasia in preterm infants via the targeting of NEDD4L-ENaC pathway

Progress of some apoptosis-related microRNAs in bronchopulmonary dysplasia

Hyperoxia Exposure Upregulates Dvl-1 and Activates Wnt/β-catenin Signaling Pathway in Newborn Rat Lung

[Effects of Prolonged Exposure of High Concentration of Oxygen on Expression of Vascular Endothelial Growth Factor and Its Receptors in Neonatal Rat Lungs].

Alteration of TGF-β-ALK-Smad Signaling in Hyperoxia-Induced Bronchopulmonary Dysplasia Model of Newborn Rats.

Effects of hyperoxia on lung vascular development and expression of angiopoietin-1 in neonatal rat lungs

Hyperoxia-Induced miR-195 Causes Bronchopulmonary Dysplasia in Neonatal Mice

Expression of Placental Growth Factor in Neonatal Rat Lungs after 85% Hyperoxia Exposure

Deficiency of endothelial FGFR1 alleviates hyperoxia-induced bronchopulmonary dysplasia in neonatal mice

miRNA Signatures in Bronchopulmonary Dysplasia: Implications for Biomarkers, Pathogenesis, and Therapeutic Options.

The Role of LncRNA H19 in MAPK Signaling Pathway Implicated in the Progression of Bronchopulmonary Dysplasia

The role of rhIGF-1/BP3 in the prevention of pulmonary hypertension in bronchopulmonary dysplasia and its underlying mechanism

Vascular Endothelial Growth Factor as Molecular Target for Bronchopulmonary Dysplasia Prevention in Very Low Birth Weight Infants

MicroRNA-30a As a Candidate Underlying Sex-Specific Differences in Neonatal Hyperoxic Lung Injury: Implications for BPD.

Recent Advances on Microrna and Bronchopulmonary Dysplasia